MedPath
FDA Approval

Daraprim

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
November 11, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pyrimethamine(25 mg in 1 1)

Manufacturing Establishments3

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fukuzyu Pharmaceutical Co., Ltd.

Vyera Pharmaceuticals LLC

692442510

Patheon Manufacturing Services LLC

Vyera Pharmaceuticals LLC

079415560

Novitium Pharma LLC

Vyera Pharmaceuticals LLC

080301870

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Daraprim

Product Details

NDC Product Code
69413-330
Application Number
NDA008578
Marketing Category
NDA (C73594)
Route of Administration
ORAL
Effective Date
November 24, 2021
STARCH, POTATOInactive
Code: 8I089SAH3TClass: IACT
STARCH, CORNInactive
Code: O8232NY3SJClass: IACT
Code: Z3614QOX8WClass: ACTIBQuantity: 25 mg in 1 1
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98GClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath